Compound Summary
药名: | przewalskin d |
分子式: | C20H26O2 |
Smiles: | CC(C)C1=C(C(=C2C=C3C=CCC(C3CCC2=C1)(C)C)O)O |
成分: | HBIN040987 |
OB_score: | 18.173978 |
SymMap_id: | SMIT08576 |
TCMID_id: | 17996 |
TCMSP_id: | MOL007066 |
PubChem_id: | 101375853 |
植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
---|
TCMBANKHE003752 | Radix Salviae liguliobae | 丹参 | To remove blood stasis and relieve pain, to promote the flow of blood and stimulate menstrual discharge, and to ease the mind./Angina pectoris, cerebral atherosclerosis, diffusive intravascular clotting, thrombophlebitis, hepatitis, acute surgical infection, mastitis, erysipelas, otitis media, tonsillitis, bone marrow infection, menstrual disorder, dysmenorrhea, amenorrhea, postpartum stasis stagnation abdominal pain, pain in heart and abdomen, concretion conglomeration accumulation and gathering, heat impediment swelling and pain, knocks and falls, heat entering construction-blood, vexation and agitation, insomnia and vexation, swelling toxin of welling abscess and sore, zoster, neurodermatitis, psoriasis. | |||
TCMBANKHE005432/YNS-47/YEM-51/XU-527 | Salvia przewalskii|Salvia przewalskii Maxim.var.mandarinorum(Diels) Stib.|Salvia przewalskii Maxim. | 甘西鼠尾草|褐毛甘西鼠尾|甘西鼠尾 | 大紫丹参|甘西鼠尾 | 云南药材标准:第七册|云南民族药物志:第一卷|西藏昌都市芒康县 | 活血化瘀,通经止痛,清心安神。用于胸痹心痛,心烦失眠,脘腹胁痛,痛经、经闭、产后恶露不尽,风湿痹痛,癥瘕,疮疡肿痛。|See Salvia miltiorrhiza ./See Salvia miltiorrhiza . | 彝族/藏族 |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE000201 | ESR1 | ER; ESR; ESRA; ESTRR; Era; NR3A1 | estrogen receptor 1 |
TCMBANKGE000286 | GSK3B | - | glycogen synthase kinase 3 beta |
TCMBANKGE000309 | SCN5A | CDCD2; CMD1E; CMPD2; HB1; HB2; HBBD; HH1; ICCD; IVF; LQT3; Nav1.5; PFHB1; SSS1; VF1 | sodium voltage-gated channel alpha subunit 5 |
TCMBANKGE000425 | DRD1 | DADR; DRD1A | dopamine receptor D1 |
TCMBANKGE000633 | ADRB2 | ADRB2R; ADRBR; B2AR; BAR; BETA2AR | adrenoceptor beta 2 |
TCMBANKGE000701 | ESR2 | ER-BETA; ESR-BETA; ESRB; ESTRB; Erb; NR3A2; ODG8 | estrogen receptor 2 |
TCMBANKGE000766 | ACHE | ACEE; ARACHE; N-ACHE; YT | acetylcholinesterase (Cartwright blood group) |
TCMBANKGE000813 | DPP4 | ADABP; ADCP2; CD26; DPPIV; TP103 | dipeptidyl peptidase 4 |
TCMBANKGE000965 | CHRNA7 | CHRNA7-2; NACHRA7 | cholinergic receptor nicotinic alpha 7 subunit |
TCMBANKGE001073 | PTGS2 | COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2 | prostaglandin-endoperoxide synthase 2 |
TCMBANKGE001194 | ADRA2A | ADRA2; ADRA2R; ADRAR; ALPHA2AAR; ZNF32 | adrenoceptor alpha 2A |
TCMBANKGE001506 | ADRA1B | ADRA1; ALPHA1BAR | adrenoceptor alpha 1B |
TCMBANKGE001943 | ADRA1D | ADRA1; ADRA1A; ADRA1R; ALPHA1; DAR; dJ779E11.2 | adrenoceptor alpha 1D |
TCMBANKGE003157 | CHRM2 | HM2 | cholinergic receptor muscarinic 2 |
TCMBANKGE003625 | SLC6A4 | 5-HTT; 5-HTTLPR; 5HTT; HTT; OCD1; SERT; SERT1; hSERT | solute carrier family 6 member 4 |
TCMBANKGE004266 | AR | AIS; AR8; DHTR; HUMARA; HYSP1; KD; NR3C4; SBMA; SMAX1; TFM | androgen receptor |
TCMBANKGE005535 | CHRM1 | HM1; M1; M1R | cholinergic receptor muscarinic 1 |
TCMBANKGE006943 | CHRM3 | EGBRS; HM3; PBS | cholinergic receptor muscarinic 3 |
TCMBANKGE008124 | ADRA2B | ADRA2L1; ADRA2RL1; ADRARL1; ALPHA2BAR; FAME2; alpha-2BAR | adrenoceptor alpha 2B |
TCMBANKGE008702 | OPRM1 | LMOR; M-OR-1; MOP; MOR; MOR1; OPRM | opioid receptor mu 1 |
TCMBANKGE009256 | SLC6A2 | NAT1; NET; NET1; SLC6A5 | solute carrier family 6 member 2 |
TCMBANKGE009455 | CHRM5 | HM5 | cholinergic receptor muscarinic 5 |
TCMBANKGE011923 | CHRM4 | HM4; M4R | cholinergic receptor muscarinic 4 |
TCMBANKGE012155 | SLC6A3 | DAT; DAT1; PKDYS; PKDYS1 | solute carrier family 6 member 3 |
TCMBANKGE013826 | DRD5 | DBDR; DRD1B; DRD1L2 | dopamine receptor D5 |
TCMBANKGE014050 | GABRA1 | ECA4; EIEE19; EJM; EJM5 | gamma-aminobutyric acid type A receptor subunit alpha1 |
TCMBANKGE014423 | ADRA1A | ADRA1C; ADRA1L1; ALPHA1AAR | adrenoceptor alpha 1A |